Everything below concerns tissue repair. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2025-11-13. Numbers and descriptions here follow the published literature rather than marketing material.
Terminology in the literature is not fully standardised. Papers and product listings use BPC-157, BPC 157, and the longer phrase stable gastric pentadecapeptide BPC 157 interchangeably, and synonyms such as bepecin or PL 14736 appear in older or company-linked publications. Purity claims and reported masses can also differ between sources because peptide preparations may include counterions, residual solvents, or bound water. This variability complicates direct comparison of results across studies and makes the exact identity and grade of a given sample worth verifying. Discussions of the compound should therefore specify the source, salt form, and stated purity where those are known.
BPC-157 is a synthetic peptide composed of fifteen amino acid residues, with the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. Its name derives from body protection compound, a term used for a protein fraction identified in human gastric juice. Researchers in Zagreb first reported the pentadecapeptide in the early 1990s and described it as a stable fragment of that larger protein. The compound is also catalogued as PL 14736 and, in some commercial contexts, as bepecin. Its molecular formula is C62H98N16O22 and its monoisotopic mass is approximately 1419 daltons.
Most published work on BPC-157 consists of preclinical studies, including rodent models of tissue injury, gastrointestinal lesions, and vascular or tendon damage, together with in vitro cell assays. Reviews frequently note that the mechanisms proposed in these papers remain incompletely characterised and that findings have not been confirmed in large randomised human trials. The compound is widely sold as a research chemical rather than a licensed medicine, and labels commonly carry a statement that it is not for human use. Whether any of the reported animal effects translate to humans is an open question rather than an established result.
Some properties, such as the peptide's sequence and molecular mass, are firmly established. Other claims, particularly about mechanism and clinical benefit, remain open questions. Proposed mechanisms include effects on nitric oxide signaling and on cell migration, but these are hypotheses supported by limited evidence. Reviewers often note that the field lacks large controlled human trials. Positive animal findings are best treated as signals for further study rather than as settled conclusions.
Most published studies examine BPC-157 in animal models rather than in humans. Common subjects include rats and mice, and researchers often use models of tissue injury, surgery, or induced inflammation. Reported endpoints include healing rates, blood vessel formation, and markers of tissue repair. These designs provide controlled comparisons, but findings in animals do not automatically transfer to people. Human clinical data remain limited and are frequently described as preliminary.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C62H98N16O22 | Computed for the free peptide |
| Monoisotopic mass | Approximately 1419 Da | Reported values shift with counterion and hydration |
| Residue count | 15 amino acids | Sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val |
| Origin | Fragment of human gastric juice protein | First described in early 1990s research reports |
| Common synonyms | BPC 157; PL 14736; bepecin | Naming varies across papers and catalogues |
Most early work on this peptide originated in the 1990s from a research group in Zagreb, Croatia, relying on animal models and cell cultures. Reported observations included effects on gastrointestinal lesion healing, tendon fibroblast migration, and blood vessel formation under controlled laboratory conditions. These findings come predominantly from rodent studies and in vitro assays rather than from human trials. Controlled human data remain limited, and the degree to which animal results translate to human physiology is an open question rather than a settled fact.
Within the research literature, the peptide is discussed through several provisional mechanisms, including cytoprotection, modulation of growth factor signaling, and interaction with the nitric oxide system. None of these mechanisms is fully characterized, and no single pathway is universally accepted. Review articles typically note the gap between consistent animal findings and sparse human evidence. The compound is classified as a research chemical rather than an approved pharmaceutical, which shapes how studies are designed, funded, and reported.
BPC-157 is a synthetic pentadecapeptide with the sequence GEPPPGKPADDAGLV, corresponding to a partial fragment of a larger protein detected in human gastric juice. The name derives from the parent protein designation BPC, an abbreviation of body protection compound, with 157 acting as a fraction or batch identifier used by the original investigators. Its molecular weight is approximately 1419 daltons, and the chain contains no unusual residues or disulfide bridges. In the literature it is described as a short, water-soluble fragment rather than a complete natural protein.
Interest in the peptide has grown through online communities that discuss self-administered use, which sits outside formal research settings. Regulatory status varies by country, and in many jurisdictions the compound is not approved as a therapeutic product. Questions about optimal routes of administration, long-term effects, and dose-response relationships remain open. Published pharmacokinetic data in humans are limited, and much of what circulates in popular discussion is extrapolated from animal work rather than measured directly in people.
BPC-157 is a synthetic peptide built from fifteen amino acids, referred to in the literature as a pentadecapeptide. Its sequence was derived from a larger protein found in human gastric juice, commonly called body protection compound. Researchers first described the fragment in the early 1990s and named it after the parent protein plus a numeric identifier. The peptide does not correspond to a single marketed medicine; it is primarily a laboratory research material. Suppliers distribute it as a lyophilized powder intended for experimental use.
=== Honors College === The University of Arizona W.A. Franke Honors College provides a program for over 4,500 students that creates a smaller community feel like that of a liberal arts college within a large research institution. It started in 1962 with an acceptance of seventy-five students and has grown to 5,508 in the academic year 2016–2017. It was renamed from the Honors College to the W.A. Franke Honors College in recognition of a $25 million gift commitment made by William A. "Bill" Franke.
The proliferation of such warehouse and superstores has contributed to the continuing disappearance of smaller, local grocery stores, the increased dependence on the automobile, and suburban sprawl because of the necessity for large floor space and increased vehicular traffic. For example, in 2009 51% of Wal-Mart's $251 billion domestic sales were recorded from grocery goods. Some critics consider the chains' common practice of selling loss leaders to be anti-competitive. They are also wary of the negotiating power that large, often multinationals have with suppliers around the world.
=== Worms === The microscopic soil-dwelling nematode roundworms Panagrolaimus detritophagus and Plectus parvus are the only eukaryotic organisms that have been proven to be viable after cryopreservation for many years (30,000 to 40,000 years). In this case, the preservation was natural rather than artificial, due to permafrost. They came alive when warmed up.
These higher frequencies permit the great bandwidth required for television broadcasting. Since natural and artificial noise sources are less present at these frequencies, high-quality audio transmission is possible, using frequency modulation.
protein purification Any process by which one or more specific proteins are isolated from a heterogeneous mixture such as whole cells or tissues, usually by first separating the protein and non-protein components of the mixture and then by separating the protein(s) of interest from all other non-target proteins. Purification is often necessary in order to remove contaminants that might interfere with the study of the protein of interest's structure, function, and interactions with other molecules. A wide variety of isolation techniques exist, most of which exploit differences in the size, solubility, binding affinity, enzymatic activity, or other physico-chemical properties of the separated components. Some techniques tend to destroy higher-order structure and thus are only useful for identification of the protein's primary amino acid sequence, while others are designed to preserve the structure and function of the protein's native state.
Sources: en.wikipedia.org
=== Production of chlorocarbons === Mercury-based catalysis is woven throughout the history of chlorinated ethanes and ethylenes. Vinyl chloride is produced by the addition of HCl to acetylene using a mercury-carbon catalyst. Considerable effort is required to limit the contamination of the product with mercury.
=== Protein === This 1686-amino acid protein belongs to the ADAMTS family and is one of 19 members known in humans. It is a large, multi-domain enzyme that undergoes extensive post-translational modifications, including N- and O-linked glycosylation, chondroitin sulfate attachment, and potential C-mannosylation and O-fucosylation of the thrombospondin (TSP) type 1 domains. The domain structure from the N-terminus to the C-terminus consists of:
Charged analytes have a more complex interaction in the capillary because they exhibit electrophoretic mobility, engage in electrostatic interactions with the micelle, and participate in hydrophobic partitioning. The fraction of the sample in the aqueous phase,
Some Māori tribes from New Zealand would keep mummified heads as trophies from tribal warfare. They are also known as Mokomokai. In the 19th century, many of the trophies were acquired by Europeans who found the tattooed skin to be a phenomenal curiosity. Westerners began to offer valuable commodities in exchange for the uniquely tattooed mummified heads. The heads were later put on display in museums, 16 of them in France alone. In 2010, at a ceremony in the Hôtel de Ville in Rouen, Rouen City Council returned one of the heads to New Zealand, despite earlier protests by the Culture Ministry of France. There is also evidence that some Māori tribes may have practiced full-body mummification, though the practice is not thought to have been widespread. The discussion of Māori mummification has been historically controversial, with some experts in past decades claiming that such mummies have never existed. The historical significance of full-body mummification within Māori culture is acknowledged by science, although there is still debate as to the nature of their exact mummification processes. Some mummies appear to have been spontaneously created by the natural environment, while others exhibit signs of direct human involvement. Generally, modern consensus tends to agree that there could have been a mixture of both types of mummification, similar to that of the Ancient Egyptian culture.
Sources: en.wikipedia.org
PROSITE Database of protein families and domains SCOP Structural classification of Proteins CATH Class Architecture Topology Homology FSSP FSSP PASS2 PASS2 - Protein Alignments as Structural Superfamilies SMoS SMoS - Database of Structural Motifs of Superfamily Archived 2007-01-26 at the Wayback Machine S4 S4: Server for Super-Secondary Structure Motif Mining
== Gas-phase reactions == One of the oldest known chemiluminescent reactions is that of elemental white phosphorus oxidizing in moist air, producing a green glow. This is a gas-phase reaction of phosphorus vapor, above the solid, with oxygen producing excited states of (PO)2 and HPO. Another gas phase reaction is the basis of nitric oxide detection in commercial analytic instruments applied to environmental air-quality testing. Ozone (O3) is combined with nitric oxide (NO) to form nitrogen dioxide (NO2) in an activated state [◊]:
Dr Christopher John Kent. Organist. For services to Music and Musicology. Azam Ahmed Khan. Executive Officer, Department for Work and Pensions and Founder, The Akhirah Team. For Charitable Services. William James David King. For services to Association Football in Northern Ireland. Gwendoline May Kingdon. For services to the community in South Molton, Devon. Elizabeth McDonald Kinnear. Volunteer, Guide Dogs Perth and District Branch. For services to Guide Dogs for the Blind in Perthshire. Juan Kotze. OCS Contracted Security Lead and Head of VIP Relations, Ministry of Justice. For Public Service. Kathleen Louisa Kynaston. Lately Chair, Shrewsbury Amateur Swimming Club. For services to Swimming and to the community in Shropshire. Rachael Isabel Lake. For services to the community in Walton on Thames, Surrey. Marino Teddy Michel Latour. Designated Safeguarding Professional, NHS South West London Integrated Care Board. For services to Safeguarding Adults. Amanda Jayne Lear. Enforcement Case Manager, Department for Work and Pensions. For services to the community in Moreton, Merseyside. Diana Rosemary Lee. For services to the community in Collingham, West Yorkshire. Frances Christina Lee. For services to the community in Acocks Green, West Midlands. Stephen Roger Lees JP. For services to the communities in Himley, Swindon and South Staffordshire. Morag Linda Lightning. Vice Chair, Turriff and District Community Council. For services to the community in Turriff, Aberdeenshire, particularly during Covid-19. Henry Lillystone. Fixtures Secretary, Leicestershire Foxes Sunday League.
If, in addition, the rate of photoionization is greater than the rate of consumption of intermediates, then each selected state is converted to one electron plus one positive ion, so that the RIS process is saturated. A usually efficient way to produce free atoms of an element in the ground state is to atomize the elements by ion sputtering or thermal vaporization of the element from a laser matrix under vacuum conditions or at environments with pressures significantly less than normal atmospheric pressure. The resulting plume of secondary atoms is then channeled through the path of multiple tuned laser beams which are capable of exciting consecutive electronic transitions in the specified element. Light from these tuned lasers promotes the desired atoms above their ionization potentials whereas interfering atoms from other elements are hardly ionized since they are generally transparent to the laser beam. This process produces photoions which are extracted and directed towards an analytical facility such as a magnetic sector to be counted. This approach is extremely sensitive to atoms of the specified element so that the ionization efficiency is almost 100% and also elementally selective, due to the highly unlikely chance that other species will be resonantly ionized. To achieve high ionization efficiencies, monochromatic lasers with high instantaneous spectral power are used. Typical lasers being used include continuous-wave lasers with extremely high spectral purity and pulsed lasers for analyses involving limited atoms.
== Personal life == Tiu Laurel was married to Francesca Carla Winebrenner, an actress known by the stage name Cheska Iñigo and a member of the board of director of Winebrenner & Iñigo Insurance Brokers, Inc. He is currently partnered with Yana, a Ukrainian. He has three children. His daughter Kei is a managing director of Frabelle Group and is married with two children as of 2018, making him a grandfather. His son Miko was an equestrian for Sarah Lawrence College during its 2014–15 campaign.
Sources: en.wikipedia.org
BPC-157 is a synthetic fifteen-amino-acid peptide whose sequence corresponds to a fragment of a protein found in human gastric juice. It is studied mainly in preclinical research and is not an approved pharmaceutical product in major markets. Materials sold for laboratory use are typically labelled as research chemicals.
No medicines regulator in the United States or the European Union has approved BPC-157 as a therapeutic product. Presenting it as a drug or as a dietary supplement ingredient would generally not match its regulatory status. Availability as a research chemical does not imply clinical approval.
Published reports rest largely on animal models and cell culture rather than controlled human trials. Review articles describe the proposed mechanisms as incompletely understood. Conclusions about effects in humans therefore remain tentative.
Human data are limited. Most evidence comes from animal experiments and from small or uncontrolled reports. The absence of large trials means clinical effects and safety are not firmly established.